688739 成大生物
已收盘 01-06 15:00:01
资讯
新帖
简况
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,1月6日股价上涨0.58%
证券之星 · 01-06 17:50
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,1月6日股价上涨0.58%
每周股票复盘:成大生物(688739)部分募投项目延期并调整结构
证券之星 · 01-02
每周股票复盘:成大生物(688739)部分募投项目延期并调整结构
成大生物(688739)披露部分募投项目延期及调整内部投资结构公告,12月31日股价下跌0.23%
证券之星 · 2025-12-31
成大生物(688739)披露部分募投项目延期及调整内部投资结构公告,12月31日股价下跌0.23%
每周股票复盘:成大生物(688739)拟增资1亿元实施疫苗项目
证券之星 · 2025-12-28
每周股票复盘:成大生物(688739)拟增资1亿元实施疫苗项目
成大生物一月内终止6个疫苗项目,核心产品市占率与价格双降,业绩连跌如何破局?
新浪证券 · 2025-12-25
成大生物一月内终止6个疫苗项目,核心产品市占率与价格双降,业绩连跌如何破局?
成大生物(688739)披露部分募投项目延期及调整计划,12月24日股价上涨0.58%
证券之星 · 2025-12-24
成大生物(688739)披露部分募投项目延期及调整计划,12月24日股价上涨0.58%
成大生物(688739)披露部分募投项目内部投资结构调整公告,12月19日股价上涨0.34%
证券之星 · 2025-12-19
成大生物(688739)披露部分募投项目内部投资结构调整公告,12月19日股价上涨0.34%
1个月终止6个研发子项目,成大生物应提升决策能力,确保资金用在“刀刃”上
每日经济新闻 · 2025-12-19
1个月终止6个研发子项目,成大生物应提升决策能力,确保资金用在“刀刃”上
成大生物(688739)披露关于2025年第二次临时股东会增加临时提案暨延期召开的公告,12月18日股价上涨0.38%
证券之星 · 2025-12-18
成大生物(688739)披露关于2025年第二次临时股东会增加临时提案暨延期召开的公告,12月18日股价上涨0.38%
成大生物最新公告:调整部分募集资金投资项目内部投资结构
证券之星 · 2025-12-18
成大生物最新公告:调整部分募集资金投资项目内部投资结构
成大生物:拟续聘致同会计师事务所为2025年度审计机构
证券日报网 · 2025-12-07
成大生物:拟续聘致同会计师事务所为2025年度审计机构
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,12月01日股价上涨0.15%
证券之星 · 2025-12-01
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,12月01日股价上涨0.15%
每周股票复盘:成大生物(688739)将召开2025年第三季度业绩说明会
证券之星 · 2025-11-23
每周股票复盘:成大生物(688739)将召开2025年第三季度业绩说明会
成大生物(688739)披露召开2025年第三季度业绩说明会,11月20日股价下跌0.26%
证券之星 · 2025-11-20
成大生物(688739)披露召开2025年第三季度业绩说明会,11月20日股价下跌0.26%
每周股票复盘:成大生物(688739)已回购38.49万股耗资1078.92万元
证券之星 · 2025-11-09
每周股票复盘:成大生物(688739)已回购38.49万股耗资1078.92万元
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,11月03日股价上涨0.29%
证券之星 · 2025-11-03
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,11月03日股价上涨0.29%
成大生物(688739)披露2025年第三季度报告,10月30日股价下跌1.09%
证券之星 · 2025-10-30
成大生物(688739)披露2025年第三季度报告,10月30日股价下跌1.09%
图解成大生物三季报:第三季度单季净利润同比下降61.17%
证券之星 · 2025-10-29
图解成大生物三季报:第三季度单季净利润同比下降61.17%
成大生物(688739.SH)与中国科学院微生物研究所签订战略合作协议
智通财经 · 2025-10-21
成大生物(688739.SH)与中国科学院微生物研究所签订战略合作协议
每周股票复盘:成大生物(688739)9月回购208,478股
证券之星 · 2025-10-12
每周股票复盘:成大生物(688739)9月回购208,478股
加载更多
公司概况
公司名称:
辽宁成大生物股份有限公司
所属行业:
医药制造业
上市日期:
2021-10-28
主营业务:
辽宁成大生物股份有限公司的主营业务是人用疫苗的研发、生产与销售。公司的主要产品是人用狂犬病疫苗和人用乙脑灭活疫苗。
发行价格:
110.00
{"stockData":{"symbol":"688739","market":"SH","secType":"STK","nameCN":"成大生物","latestPrice":26.21,"timestamp":1767682801000,"preClose":26.06,"halted":0,"volume":1889946,"delay":0,"changeRate":0.0058,"floatShares":416000000,"shares":416000000,"eps":0.4273,"marketStatus":"已收盘","change":0.15,"latestTime":"01-06 15:00:01","open":26.16,"high":26.24,"low":26,"amount":49430900,"amplitude":0.0092,"askPrice":26.23,"askSize":55,"bidPrice":26.21,"bidSize":142,"shortable":0,"etf":0,"ttmEps":0.4273,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767749400000},"marketStatusCode":5,"adr":0,"adjPreClose":26.06,"symbolType":"stock_kcb","openAndCloseTimeList":[[1767663000000,1767670200000],[1767675600000,1767682800000]],"highLimit":28.67,"lowLimit":23.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":416450000,"isCdr":false,"pbRate":1.16,"roa":"--","peRate":61.338638,"roe":"1.74%","epsLYR":0.83,"committee":-0.624277,"marketValue":10915000000,"turnoverRate":0.0045,"status":0,"afterMarket":{"amount":0,"volume":0,"close":26.21,"buyVolume":0,"sellVolume":0,"time":1767684837558,"indexStatus":"已收盘 01-06 15:30:00","preClose":26.06},"floatMarketCap":10915000000},"requestUrl":"/m/hq/s/688739","defaultTab":"news","newsList":[{"id":"2601932418","title":"成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,1月6日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601932418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601932418?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:50","pubTimestamp":1767693030,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘,成大生物报收于26.21元,较前一交易日上涨0.58%,最新总市值为109.15亿元。该股当日开盘26.16元,最高26.24元,最低26.0元,成交额达4943.09万元,换手率为0.45%。近日,辽宁成大生物股份有限公司发布关于以集中竞价交易方式回购公司股份的进展公告。公司表示,本次回购进展符合相关法律法规及公司内部规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600030546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2600039119","title":"每周股票复盘:成大生物(688739)部分募投项目延期并调整结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2600039119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600039119?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:14","pubTimestamp":1767298452,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,成大生物报收于26.17元,较上周的26.24元下跌0.27%。本次股东会于2025年12月31日以现场和网络投票方式召开,审议通过了关于部分募投项目延期、调整内部投资结构并向全资子公司增资、部分募集资金投资项目内部投资结构调整及续聘会计师事务所的议案。表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2595244777","title":"成大生物(688739)披露部分募投项目延期及调整内部投资结构公告,12月31日股价下跌0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595244777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595244777?lang=zh_cn&edition=full","pubTime":"2025-12-31 22:32","pubTimestamp":1767191539,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,成大生物报收于25.76元,较前一交易日下跌0.23%,最新总市值为107.28亿元。该股当日开盘25.82元,最高25.88元,最低25.72元,成交额达2506.38万元,换手率为0.23%。本次股东会于2025年12月31日以现场和网络投票方式召开,审议通过了关于部分募投项目延期、调整内部投资结构并向全资子公司增资、部分募集资金投资项目内部投资结构调整及续聘会计师事务所的议案。表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100045005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2594247496","title":"每周股票复盘:成大生物(688739)拟增资1亿元实施疫苗项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247496","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247496?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:32","pubTimestamp":1766871136,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,成大生物报收于26.17元,较上周的26.24元下跌0.27%。本周,成大生物12月26日盘中最高价报26.29元。本周关注点公司公告汇总:成大生物拟向全资子公司增资10,000万元用于实施“流感病毒裂解疫苗(高剂量)”项目。公司还拟续聘致同会计师事务所为2025年度审计机构,预计审计费用合计不超过70万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159646","688739"],"gpt_icon":0},{"id":"2594623524","title":"成大生物一月内终止6个疫苗项目,核心产品市占率与价格双降,业绩连跌如何破局?","url":"https://stock-news.laohu8.com/highlight/detail?id=2594623524","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594623524?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:36","pubTimestamp":1766655360,"startTime":"0","endTime":"0","summary":"近日,辽宁成大生物股份有限公司宣布终止“b型流感嗜血杆菌结合疫苗”的研发。这已是本月内该公司第6个宣告终止的疫苗子项目。在国产疫苗市场竞争日趋激烈的背景下,这家曾经凭借人用狂犬病疫苗占据市场主导地位的企业,正面临核心产品收入萎缩、新研发管线收缩、业绩连续三年下滑的多重挑战。但截至2025年10月31日,该项目已投入募集资金4.82亿元,近期却密集终止包括Hib疫苗在内的6个子项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-12-25/doc-inhczhsf8850686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159646","688739","BK0239"],"gpt_icon":0},{"id":"2593408232","title":"成大生物(688739)披露部分募投项目延期及调整计划,12月24日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593408232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593408232?lang=zh_cn&edition=full","pubTime":"2025-12-24 23:00","pubTimestamp":1766588445,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘,成大生物报收于26.06元,较前一交易日上涨0.58%,最新总市值为108.53亿元。该股当日开盘25.98元,最高26.09元,最低25.86元,成交额达2249.58万元,换手率为0.21%。近日,成大生物发布关于2025年第二次临时股东会会议资料的公告。公司还拟续聘致同会计师事务所为2025年度审计机构,预计审计费用合计不超过70万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400041644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2592985841","title":"成大生物(688739)披露部分募投项目内部投资结构调整公告,12月19日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592985841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592985841?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:30","pubTimestamp":1766154656,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘,成大生物报收于26.24元,较前一交易日上涨0.34%,最新总市值为109.28亿元。该股当日开盘26.13元,最高26.35元,最低26.12元,成交额达3531.38万元,换手率为0.32%。近日,成大生物发布公告称,公司拟对部分募集资金投资项目进行内部投资结构调整。同时,公司还对生物技术产品研发生产基地项目的内部投资结构进行调整,增加土建投资,减少设备及净化工程投入,以提升项目建设质量。上述事项已通过董事会审议,尚需提交股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900039518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000860.SH","688739"],"gpt_icon":0},{"id":"2592736132","title":"1个月终止6个研发子项目,成大生物应提升决策能力,确保资金用在“刀刃”上","url":"https://stock-news.laohu8.com/highlight/detail?id=2592736132","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592736132?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:07","pubTimestamp":1766113620,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 公司快评 | 1个月终止6个研发子项目,成大生物应提升决策能力,确保资金用在“刀刃”上。 成大生物在一个月内密集终止6个研发子项目,这一行为在市场竞争加剧和业绩承压的背景下显得尤为突出。 成大生物2025年前三季度营收与归母净利润双双下滑,实现营收10.96亿元,同比降幅15.88%;归母净利润1.65亿元,同比大幅下降50.01%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-19/doc-inhcicem5855654.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-19/doc-inhcicem5855654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2592904738","title":"成大生物(688739)披露关于2025年第二次临时股东会增加临时提案暨延期召开的公告,12月18日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592904738","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592904738?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:28","pubTimestamp":1766068080,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘,成大生物报收于26.15元,较前一交易日上涨0.38%,最新总市值为108.9亿元。近日,辽宁成大生物股份有限公司发布公告称,因控股股东辽宁成大提请增加临时提案《关于部分募集资金投资项目内部投资结构调整的议案》,公司决定将2025年第二次临时股东会召开时间由原定的2025年12月23日延期至2025年12月31日,股权登记日仍为2025年12月16日。网络投票将于会议当日通过上交所系统进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800038915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2592970434","title":"成大生物最新公告:调整部分募集资金投资项目内部投资结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2592970434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592970434?lang=zh_cn&edition=full","pubTime":"2025-12-18 19:31","pubTimestamp":1766057465,"startTime":"0","endTime":"0","summary":"成大生物(688739.SH)公告称,公司拟对部分募集资金投资项目的内部投资结构进行调整,包括终止“人用疫苗研发项目”下的b型流感嗜血杆菌结合疫苗(hib疫苗)子项目,以及优化调整“生物技术产品研发生产基地项目”的内部投资结构。此次调整不涉及投资总额、实施主体及实施地点的变更,旨在优化募集资金使用效率。相关议案已通过董事会审议,尚需提交股东会审议。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800031637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2589870507","title":"成大生物:拟续聘致同会计师事务所为2025年度审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870507","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589870507?lang=zh_cn&edition=full","pubTime":"2025-12-07 20:38","pubTimestamp":1765111080,"startTime":"0","endTime":"0","summary":"证券日报网讯12月5日晚间,成大生物发布公告称,公司拟续聘致同会计师事务所(特殊普通合伙)为2025年度财务报告及内部控制审计机构,审计费用总额不超过70万元,其中财务审计费用55万元、内控审计费用15万元,与2024年度持平,该事项尚需12月23日股东会审议通过。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyxcz3133457.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyxcz3133457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2588775666","title":"成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,12月01日股价上涨0.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588775666","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588775666?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:27","pubTimestamp":1764599257,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘,成大生物报收于26.8元,较前一交易日上涨0.15%,最新总市值为111.61亿元。该股当日开盘26.69元,最高26.88元,最低26.67元,成交额达3561.89万元,换手率为0.32%。近日,辽宁成大生物股份有限公司发布关于以集中竞价交易方式回购公司股份的进展公告。公司表示,本次回购进展符合相关法律法规及公司回购方案的规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100036951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2585477103","title":"每周股票复盘:成大生物(688739)将召开2025年第三季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2585477103","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585477103?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:53","pubTimestamp":1763837589,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘,成大生物报收于26.48元,较上周的28.17元下跌6.0%。本周,成大生物11月17日盘中最高价报28.39元。公司公告汇总辽宁成大生物股份有限公司将于2025年11月28日上午9:00-10:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会,介绍公司2025年第三季度报告的经营成果和财务状况。投资者可于2025年11月21日至11月27日16:00前通过上证路演中心网站或公司邮箱提交问题,公司在说明会上将对普遍关注的问题进行回应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2584713052","title":"成大生物(688739)披露召开2025年第三季度业绩说明会,11月20日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584713052","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584713052?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:23","pubTimestamp":1763648599,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘,成大生物报收于27.28元,较前一交易日下跌0.26%,最新总市值为113.61亿元。公司近日发布公告称,辽宁成大生物股份有限公司将于2025年11月28日上午9:00-10:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会,介绍公司2025年第三季度报告的经营成果和财务状况。投资者可于2025年11月21日至11月27日16:00前通过上证路演中心网站或公司邮箱提交问题,公司在说明会上将对普遍关注的问题进行回应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000038257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2582886481","title":"每周股票复盘:成大生物(688739)已回购38.49万股耗资1078.92万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582886481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582886481?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:39","pubTimestamp":1762634348,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘,成大生物报收于27.43元,较上周的27.42元上涨0.04%。本周,成大生物11月4日盘中最高价报27.66元。本周关注点公司公告汇总:截至2025年10月31日,成大生物已累计回购股份384,899股,支付资金总额10,789,216.56元。2025年10月未进行回购操作。后续公司将根据市场情况择机推进回购,并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2580142362","title":"成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,11月03日股价上涨0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580142362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580142362?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:48","pubTimestamp":1762181306,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘,成大生物报收于27.5元,较前一交易日上涨0.29%,最新总市值为114.52亿元。该股当日开盘27.41元,最高27.56元,最低27.33元,成交额达6103.61万元,换手率为0.53%。近日,辽宁成大生物股份有限公司发布关于以集中竞价交易方式回购公司股份的进展公告。上述回购进展符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300036393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2579116650","title":"成大生物(688739)披露2025年第三季度报告,10月30日股价下跌1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579116650","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579116650?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:59","pubTimestamp":1761818362,"startTime":"0","endTime":"0","summary":"近日,成大生物发布《2025年第三季度报告》,披露了公司前三季度主要财务数据。公告显示,年初至报告期末公司实现营业收入1,095,886,627.32元,较上年同期减少15.88%;归属于上市公司股东的净利润为164,812,017.55元,较上年同期减少50.01%。研发投入方面,年初至报告期末研发投入合计为309,677,910.03元,较上年同期减少13.68%;研发投入占营业收入的比例为28.26%,较上年同期增加0.72个百分点。截至2025年9月30日,公司回购专用证券账户持股数为5,199,548股,占公司总股本的1.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000035472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2579971649","title":"图解成大生物三季报:第三季度单季净利润同比下降61.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579971649","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579971649?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:47","pubTimestamp":1761734820,"startTime":"0","endTime":"0","summary":"证券之星消息,成大生物2025年三季报显示,前三季度公司主营收入10.96亿元,同比下降15.88%;归母净利润1.65亿元,同比下降50.01%;扣非净利润1.35亿元,同比下降56.77%;其中2025年第三季度,公司单季度主营收入3.89亿元,同比下降7.79%;单季度归母净利润4251.73万元,同比下降61.17%;单季度扣非净利润3288.14万元,同比下降67.53%;负债率4.24%,投资收益2037.55万元,财务费用-2861.52万元,毛利率79.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"gpt_icon":0},{"id":"2577784281","title":"成大生物(688739.SH)与中国科学院微生物研究所签订战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2577784281","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577784281?lang=zh_cn&edition=full","pubTime":"2025-10-21 16:08","pubTimestamp":1761034095,"startTime":"0","endTime":"0","summary":"智通财经APP讯,成大生物(688739.SH)发布公告,公司与中国科学院微生物研究所(简称“微生物所”)于近日签署《战略合作协议》,双方聚焦新发突发传染病领域,重点围绕虫媒传染病预防,联合申报国家级、省部级科研项目,协同发力应对传染病防控。此次协议属于意向性合作范畴,对公司2025年度及未来业绩不构成直接影响,对公司业绩的具体影响需视下一步具体项目推进和实施情况来确定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"成大生物(688739.SH)与中国科学院微生物研究所签订战略合作协议","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2574645021","title":"每周股票复盘:成大生物(688739)9月回购208,478股","url":"https://stock-news.laohu8.com/highlight/detail?id=2574645021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574645021?lang=zh_cn&edition=full","pubTime":"2025-10-12 02:45","pubTimestamp":1760208315,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,成大生物报收于27.3元,较上周的26.9元上涨1.49%。本周,成大生物10月10日盘中最高价报27.48元。公司公告汇总:截至2025年9月30日,累计回购384,899股,占总股本0.092%。截至2025年9月30日,已累计回购股份384,899股,占公司总股本的0.092%,支付资金总额10,789,216.56元,回购最高价为29.61元/股,最低价为27.20元/股。2025年9月单月回购208,478股,支付资金5,748,133.70元。上述回购行为符合相关规定,公司将持续推进回购并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767733250451,"stockEarnings":[{"period":"1week","weight":0.0151},{"period":"1month","weight":-0.0184},{"period":"3month","weight":-0.0257},{"period":"6month","weight":-0.0072},{"period":"1year","weight":0.0808},{"period":"ytd","weight":0.0175}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.1635},{"period":"1year","weight":0.2734},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"辽宁成大生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24286人(较上一季度减少4.17%)","perCapita":"17147股","listingDate":"2021-10-28","address":"辽宁省沈阳市浑南区新放街1号","registeredCapital":"41645万元","survey":" 辽宁成大生物股份有限公司的主营业务是人用疫苗的研发、生产与销售。公司的主要产品是人用狂犬病疫苗和人用乙脑灭活疫苗。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"成大生物(688739)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供成大生物(688739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"成大生物,688739,成大生物股票,成大生物股票老虎,成大生物股票老虎国际,成大生物行情,成大生物股票行情,成大生物股价,成大生物股市,成大生物股票价格,成大生物股票交易,成大生物股票购买,成大生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"成大生物(688739)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供成大生物(688739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}